Finance

Lists
C1AH34:BVMF
Cardinal Health Inc Brazilian Depositary Receipt
1 166,96 R$
0,00%
(0,00) 1D
7 ოქტ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for C1AH34...
Open
1 182,04 R$
High
1 182,04 R$
Low
1 163,48 R$
Mkt. cap
53,76 მლრდ.
Avg. vol.
11,00
Volume
13,00
52-wk high
1 274,52 R$
52-wk low
901,39 R$
Shares outstanding
231,56 მლნ.
No. of employees
61 ათ.
Open
1 182,04 R$
High
1 182,04 R$
Low
1 163,48 R$
Mkt. cap
53,76 მლრდ.
Avg. vol.
11,00
Volume
13,00
52-wk high
1 274,52 R$
52-wk low
901,39 R$
Shares outstanding
231,56 მლნ.
No. of employees
61 ათ.
News stories
From web sources and news partners
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health Inc Brazilian Depositary Receipt
CEOჯეისონ ჰოლარ
Employees61,3 ათ.
Founded1971
HeadquartersDublin, ოჰაიო, ამერიკის შეერთებული შტატები
SectorHealth care provider
Last report
11 აგვ. 2026
Fiscal period
Q4 2026
2,60 US$ / 2,42 US$
+7,41%beat
Revenue / Est. (USD)
63,67 მლრდ. / 65,11 მლრდ.
-2,20%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
64,01 მლრდ.
65,63 მლრდ.
60,94 მლრდ.
63,67 მლრდ.
Cost of goods sold
61,69 მლრდ.
63,23 მლრდ.
58,44 მლრდ.
61,11 მლრდ.
Cost of revenue
61,69 მლრდ.
63,23 მლრდ.
58,44 მლრდ.
61,11 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 მლრდ.
1,50 მლრდ.
1,54 მლრდ.
1,62 მლრდ.
Operating expense
1,55 მლრდ.
1,59 მლრდ.
1,64 მლრდ.
1,71 მლრდ.
Total operating expenses
63,24 მლრდ.
64,82 მლრდ.
60,08 მლრდ.
62,82 მლრდ.
Operating income
771,00 მლნ.
809,00 მლნ.
861,00 მლნ.
847,00 მლნ.
Other non operating income
10,00 მლნ.
11,00 მლნ.
-16,00 მლნ.
30,00 მლნ.
EBT including unusual items
598,00 მლნ.
630,00 მლნ.
392,00 მლნ.
554,00 მლნ.
EBT excluding unusual items
701,00 მლნ.
732,00 მლნ.
744,00 მლნ.
794,00 მლნ.
Income tax expense
144,00 მლნ.
159,00 მლნ.
12,00 მლნ.
154,00 მლნ.
Effective tax rate
24,08%
25,24%
3,06%
27,80%
Other operating expenses
-
-
-
-
Net income
450,00 მლნ.
467,00 მლნ.
399,00 მლნ.
398,00 მლნ.
Net profit margin
0,70%
0,71%
0,65%
0,62%
Earnings per share
2,55
2,63
3,17
2,60
Interest and investment income
-
-
-
-
Interest expense
-80,00 მლნ.
-88,00 მლნ.
-101,00 მლნ.
-103,00 მლნ.
Net interest expenses
-80,00 მლნ.
-88,00 მლნ.
-101,00 მლნ.
-103,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,00 მლრდ.
1,04 მლრდ.
1,11 მლრდ.
1,09 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები